文献速递瓣膜外科主动脉外科

主动脉瓣修复术的结局:德国主动脉瓣登记处的早期结果

Outcomes of aortic valve repair: early results from the German Aortic Valve Registry.
PubMed 文献 · Eur J Cardiothorac Surg · 2022-01-01

基于德国主动脉瓣登记处2011至2015年2327例主动脉瓣反流患者数据,分析主动脉瓣修复/保留主动脉瓣的根部手术的临床结局。30天死亡率为0.8%,1年生存率为97.7%(95%CI 97.1-98.3),1年无心脏不良事件生存率为85.7%(95%CI 84.2-87.1),1年内1.6%患者需再次干预。

要点

  • 主动脉瓣修复/保留瓣膜的根部手术占德国主动脉瓣手术的5%。
  • 全队列30天死亡率为0.8%,1年生存率为97.7%。
  • 1年无心脏不良事件生存率为85.7%,1年内再次干预率为1.6%。

核心结论

  • 主动脉瓣修复/保留主动脉瓣的根部手术在德国占需主动脉瓣手术患者的5%。
  • 数据表明主动脉瓣修复术后围术期和1年生存率及无心脏事件生存率非常满意。
  • 在索引手术中实施特定手术技术似乎可获得 comparable 的结局。

研究设计与样本

  • 回顾性分析德国主动脉瓣登记处2011至2015年数据,纳入2327例主动脉瓣反流患者(平均年龄55.2±15.0岁,76%为男性),占同期登记处42868例主动脉瓣手术患者的5%。
  • 研究队列按主动脉瓣修复技术分为三组:单纯主动脉瓣修复不伴根部手术(I组,n=914)、保留主动脉瓣的根部手术(即再植入或重塑)不伴瓣叶修复(II组,n=1077)、保留主动脉瓣的根部手术伴同期瓣叶修复(III组,n=336)。
  • 主要终点为主动脉瓣修复/保留主动脉瓣的根部手术后1年生存率;次要终点为1年随访时无心脏不良事件生存率和无主动脉瓣再次干预生存率。

主要发现

  • 全研究队列30天死亡率为19例(0.8%),三个亚组间无显著差异[I组4例(0.4%)vs II组14例(1.3%)vs III组1例(0.3%),P=0.054]。
  • 出院时,1445例(74%)患者无残余主动脉瓣反流,474例(24%)患者有轻度主动脉瓣反流,40例(2%)患者有中度/重度主动脉瓣反流。
  • 全研究队列1年生存率(95%置信区间)为97.7%(97.1-98.3),三个亚组间无显著差异。
  • 1年无心脏不良事件生存率(95%置信区间)为85.7%(84.2-87.1),在倾向评分加权分析中三个研究组相似。
  • 1年随访期间,共38例(1.6%)患者需要主动脉瓣再次干预,亚组间无显著差异(P=0.11)。

关键数值与推荐

  • 30天死亡率:全队列0.8%;I组0.4% vs II组1.3% vs III组0.3%(P=0.054)。
  • 出院时残余主动脉瓣反流:无残余74%,轻度24%,中度/重度2%。
  • 1年生存率:全队列97.7%(95%CI 97.1-98.3),亚组间无显著差异。
  • 1年无心脏不良事件生存率:85.7%(95%CI 84.2-87.1),倾向评分加权分析中三组相似。
  • 1年再次干预率:1.6%(38例),亚组间无显著差异(P=0.11)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Aortic valve (AV) repair is an evolving surgical strategy in the treatment of young patients with aortic regurgitation (AR) and/or aortic root aneurysm. We aimed to determine the clinical outcome following AV repair/AV-sparing root surgery using real-world data from the German Aortic Valve Registry. METHODS: A total of 2327 patients with AR (mean age 55.2 ± 15.0 years, 76% men), who underwent AV repair/AV-sparing root surgery between 2011 and 2015 (i.e. 5% of 42 868 AV surgery patients enrolled in the German Aortic Valve Registry during the same period) were included. Study cohort was subdivided according to the technique of AV repair: isolated AV repair without root surgery (group I) (n = 914), AV-sparing root surgery (i.e. reimplantation or remodelling) without cusp repair (group II) (n = 1077) and AV-sparing root surgery (i.e. reimplantation or remodelling) with simultaneous cusp repair (group III) (n = 336). Primary end point was 1-year survival after AV repair/AV-sparing root surgery. Secondary end points were freedom from cardiac adverse events and freedom from AV reinterventions at 1-year follow-up. RESULTS: Thirty-day mortality was 19 (0.8%) in the whole study cohort without significant differences in the 3 subgroups [4 (0.4%) patients in group I vs 14 (1.3%) patients in group II vs 1 (0.3%) patient in group III (P = 0.054)]. Postoperatively, 1445 (74%) patients had no residual AR, 474 (24%) patients had mild AR and 40 (2%) patients had moderate/severe AR at the time of hospital discharge. One-year survival (95% confidence interval) was 97.7% (97.1-98.3) in the whole study cohort and without significant difference among the 3 subgroups. One-year cardiac adverse event-free survival (95% confidence interval) was 85.7% (84.2-87.1) and was similar in all 3 study groups in propensity score-weighted analysis. A total of 38 (1.6%) patients required AV reintervention during a 1-year follow-up, without significant difference among subgroups (P = 0.11). CONCLUSIONS: AV repair/AV-sparing root surgery is performed in 5% of patients requiring AV surgery in Germany. Our data demonstrate very satisfactory periprocedural and 1-year survival and cardiac event-free survival after AV repair surgery. Implementation of specific surgical techniques during the index procedure seems to result in comparable outcomes.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Girdauskas E, Petersen J, Balaban Ü, et al. Outcomes of aortic valve repair: early results from the German Aortic Valve Registry. Eur J Cardiothorac Surg. 2022. PMID: 35962722. doi:10.1093/ejcts/ezac416

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。